Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

Cited by (321)

Items 201–300 of 321

1. Conformational analysis of methylphenidate: comparison of molecular orbital and molecular mechanics methods
   Kathleen M. Gilbert, William J. Skawinski, Milind Misra, Kristina A. Paris, Neelam H. Naik, Ronald A. Buono, Howard M. Deutsch, Carol A. Venanzi · 2004 · Journal of Computer-Aided Molecular Design
2. Chronic oral methylphenidate plus fluoxetine treatment in adolescent rats increases cocaine self-administration
   Daniela Senior, Madison McCarthy, Rania Ahmed, Shannon Klein, Wen Xuan Lee, Michael Hadjiargyrou, David E. Komatsu, Heinz Steiner, Panayotis K. Thanos · 2023 · Addiction Neuroscience
3. Time-varying SUVr reflects the dynamics of dopamine increases during methylphenidate challenges in humans
   Dardo G. Tomasi, Peter Manza, Jean Logan, Ehsan Shokri Kojori, Michele-Vera Yonga, Danielle S. Kroll, Dana E. Feldman, Katherine L. McPherson, Catherine L. Biesecker, Evan Dennis et al. · 2023 · Communications Biology
4. Measurement of psychological state changes at low dopamine transporter occupancy following a clinical dose of mazindol
   Yasuyuki Kimura, Jun Maeda, Makiko Yamada, Keisuke Takahata, Keita Yokokawa, Yoko Ikoma, Chie Seki, Hiroshi Ito, Makoto Higuchi, Tetsuya Suhara · 2016 · Psychopharmacology
5. Electrophysiological and Behavioral Markers of Hyperdopaminergia in DAT-KO Rats
   Zoia S. Fesenko, Maria A. Ptukha, Marcelo Mariano da Silva, R.S. Marques de Carvalho, Vassiliy Tsytsarev, Raul R. Gainetdinov, Jean Faber, Anna B. Volnova · 2024 · Biomedicines
6. Vilazodone, a selective serotonin reuptake inhibitor with diminished impact on methylphenidate-induced gene regulation in the striatum: Role of 5-HT1A receptor
   Michael Hrabak, Connor J. Moon, Carlos A. Bolaños-Guzmán, Heinz Steiner · 2023 · Molecular Neurobiology
7. Kappa opioid receptor antagonism restores phosphorylation, trafficking and behavior induced by a disease-associated dopamine transporter variant
   Felix P. Mayer, Adele Stewart, Durairaj Ragu Varman, Amy E. Moritz, James D. Foster, Anthony W. Owens, Lorena Bianchine Areal, Raajaram Gowrishankar, Michelle Velez, Kyria Wickham et al. · 2025 · Molecular Psychiatry
8. Psychopharmacology of substance misuse and comorbid psychiatric disorders
   Mahommed T. Abou-Saleh · 2004 · Acta Neuropsychiatrica
9. Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics
   Luís Augusto Rohde, T. Roman, Mara Helena Hutz · 2003 · The Pharmacogenomics Journal
10. Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse
    Carlos Roncero, Alfonso Carlos Abad, Antonio Padilla-Mata, Elena Ros‐Cucurull, Carmen Barral, Miguel Casas, Lara Grau‐López · 2016 · Current Neuropharmacology
11. The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project
    Sara Carucci, Alessandro Zuddas, Angelico Lampis, Kenneth K. C. Man, Carla Balia, Jan K. Buitelaar, Marina Danckaerts, Regina Dittmann, Federica Donno, Bruno Falissard et al. · 2024 · Journal of Attention Disorders
12. Effect of methylphenidate on mismatched visual information processing in young healthy volunteers: an event-related potential study.
    Chunyu Han, Yuping Wang, Mian Shi, Wei Mao, Wei Sun · 2015 · Europe PMC (PubMed Central)
13. Uso de la estimulación cerebral no invasiva en los trastornos psiquiátricos de la infancia: nuevas oportunidades y retos diagnósticos y terapéuticos
    Belén Rubio Morell, Alexander Rotenberg, Sergio Hernández Expósito, Álvaro Pascual‐Leone · 2011 · Revista de Neurología
14. What have positron emission tomography and ‘Zippy’ told us about the neuropharmacology of drug addiction?
    Paul D. Cumming, Daniele Caprioli, Jeffrey W. Dalley · 2010 · British Journal of Pharmacology
15. Molecular genetics and attention in ADHD
    Deborah L. Grady, Robert K. Moyzis, James M. Swanson · 2005 · Clinical Neuroscience Research
16. Methylphenidate does not enhance visual working memory but benefits motivation in macaque monkeys
    Mariann Oemisch, Kevin Johnston, Martin Paré · 2016 · Neuropharmacology
17. TRPM2 confers susceptibility to social stress but is essential for behavioral flexibility
    Chihiro Andoh, Naoya Nishitani, Emina Hashimoto, Yuma Nagai, Keizo Takao, Tsuyoshi Miyakawa, Takayuki Nakagawa, Yasuo Mori, Kazuki Nagayasu, Hisashi Shirakawa et al. · 2018 · Brain Research
18. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using
    Andrew J. Montgomery, Marie‐Claude Asselin, Lars Farde, Paul M. Grasby · 2007
19. Methylphenidate modifies activity in the prefrontal and parietal cortex accelerating the time judgment
    Tiago Lopes Farias, Victor Marinho, Valécia Carvalho, Kaline de Melo Rocha, Paulo Ramiler Alves da Silva, Francisca Janaina da Cunha Silva, Ariel Soares Teles, Daya Shankar Gupta, Pedro F. M. Ribeiro, Bruna Velasques et al. · 2019 · Neurological Sciences
20. Neurorobiology and Evidence-Based Biological Treatments for Substance Abuse Disorders
    Iliyan Ivanov, Kurt P. Schuiz, Robyn C. Palmero, Jeffrey H. Newcorn · 2006 · CNS Spectrums
21. Binding of [123I]iodobenzamide to the rat D2 receptor after challenge with various doses of methylphenidate: an in vivo imaging study with dedicated small animal SPECT
    Susanne Nikolaus, Christina Antke, Markus Beu, Konstantin Kley, Andreas Wirrwar, Joseph P. Huston, Hans‐Wilhelm Müller · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
22. Modulation of motorcortical excitability by methylphenidate in adult voluntary test persons performing a go/nogo task
    Johannes A Buchmann, Alexander Dück, Wolfgang Gierow, H. Zamorski, S. Heinicke, Hartmut Heinrich, Jacqueline Hoeppner, Thomas Klauer, Olaf Reis, Frank Haessler · 2009 · Journal of Neural Transmission
23. Producing ADHD: An ethnographic study of behavioural discourses of early childhood
    Simon F. Bailey · 2009 · Nottingham ePrints (University of Nottingham)
24. Predicting effects of methylphenidate and sulpiride on brain and cognition: A pharmaco-fMRI, PET study. Design and descriptives.
    Jessica I. Määttä, Ruben van den Bosch, Danae Papadopetraki, Lieke Hofmans, Britt I.H.M. Lambregts, Andrew Westbrook, Robbert‐Jan Verkes, Roshan Cools · 2021
25. Systemic inflammation enhances stimulant-induced striatal dopamine elevation in tobacco smokers
    Yasmin Zakiniaeiz, Jocelyn Hoye, Joseph Ryan Petrulli, Brittany LeVasseur, Gelsina Stanley, Hong Gao, Soheila Najafzadeh, Jim R. Ropchan, Nabeel Nabulsi, Yiyun Henry Huang et al. · 2022 · Brain Behavior and Immunity
26. Methylphenidate during early consolidation affects long-term associative memory retrieval depending on baseline catecholamines
    Isabella C. Wagner, Mariët van Buuren, Leonore Bovy, Richard Morris, Guillén Fernández · 2016 · Psychopharmacology
27. Genetic imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate
    Aynur Pekcanlar Akay, Gamze Çapa Kaya, Samet Köse, Çiğdem Eresen Yazıcıoğlu, Handan Özek Erkuran, Sevay Alşen Güney, Kaya Oğuz, Duygu Keskin, Burak Baykara, Neslihan İnal et al. · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
28. Metilfenidato en el tratamiento del trastorno de déficit de atención con hiperactividad en pediatría: monitorización en matrices biológicas
    Esther Papaseit, Óscar García‐Algar, Sandra Simó, Simona Pichini, Magı́ Farré · 2012 · Anales de Pediatría
29. Positron emission tomography studies in adult patients with attention-deficit/hyperactivity disorder
    Maeri Yamamoto, Toshiya Inada · 2022 · Japanese Journal of Radiology
30. Combined Overdose of Atomoxetine and Methylphenidate in a Cytochrome P450 2D6 Poor Metabolizer
    Arne Reimers, Hans K. Langsetmo · 2007 · Journal of Clinical Psychopharmacology
31. Central Nervous System: The Brain and Cerebrospinal Fluid
    S. Ted Treves, Harry T. Chugani, Blaise F. D. Bourgeois, Alvin Kuruc · 2014 · Springer eBooks
32. 123 I-Iofluopane Single-Photon Emission Computed Tomography as an Imaging Biomarker of Pre-Synaptic Dopaminergic System after Moderate-to-Severe Traumatic Brain Injury
    Kyle B. Womack, Rosemary Dubiel, Librada Callender, Cynthia Dunklin, Marie N. Dahdah, Thomas S. Harris, Michael D. Devous, Shannon B. Juengst, Kathleen Reilly Bell, Ramon R. Diaz-Arrastia et al. · 2020 · Journal of Neurotrauma
33. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders
    Oscar Gary Bukstein · 2006 · Expert Review of Neurotherapeutics
34. Catecholaminergic Modulation of Large‐Scale Network Dynamics Is Tied to the Reconfiguration of Corticostriatal Connectivity
    Justine Hill, Cole Harris Korponay, Betty Jo Salmeron, Thomas J. Ross, Amy C. Janes · 2024 · Human Brain Mapping
35. Methylphenidate Promotes a Frontoparietal-Dominant Brain State Improving Cognitive Performance: A Randomized Trial
    Weizheng Yan, Şükrü Barış Demiral, Dardo G. Tomasi, Rui Zhang, Peter Manza, Gene‐Jack Wang, Nora D. Volkow · 2025 · Journal of Neuroscience
36. Methylphenidate Ameliorates Behavioural and Neurobiological Deficits in Executive Function for Patients with Chronic Traumatic Brain Injury
    Alexander R. D. Peattie, Anne E. Manktelow, Barbara Jacquelyn Sahakian, David Krishna Menon, Emmanuel Andreas Stamatakis · 2024 · Journal of Clinical Medicine
37. Factor Structure of the Restricted Academic Situation Scale
    Sherif Karama, Leila Ben Amor, Natalie Grizenko, Antonio Ciampi, Valentin Mbékou, Marina Ter-Stepanian, Philippe Lageix, Chantal Baron, George J. Schwartz, Ridha Joober · 2008 · Journal of Attention Disorders
38. Consensus Report of the APA Work Group on Neuroimaging Markers of Psychiatric Disorders RESOURCE DOCUMENT
    Michael B. First, Cameron Carter, F. Xavier Castellanos, Daniel P. Dickstein, Wayne Curtis Drevets, Kerri L. Kim, Matthew F. Pescosolido, Scott Rausch, Karen E. Seymour, Jon-Kar Zubieta · 2012
39. Catecholaminergic modulation of trust decisions
    Cătălina E. Răţală, Sean James Fallon, Marieke E. van der Schaaf, Niels ter Huurne, Roshan Cools, Alan Gerard Sanfey · 2019 · Psychopharmacology
40. Cocaine reverses the changes in GABAA subunits and in glutamic acid decarboxylase isoenzymes mRNA expression induced by neonatal 6-hydroxydopamine
    Lucas Araújo de Azeredo, André Rosito Marquardt, Ana Paula Guedes Frazzon, Helena Maria Tannhauser Barros · 2010 · Behavioural Pharmacology
41. Withdrawal-Emergent Dyskinesia After Acute Discontinuation of Risperidone in a Child With Autism Spectrum Disorder
    Maanvi Kumar, Richard E. Mattison, Raman K. Baweja · 2018 · Journal of Clinical Psychopharmacology
42. Vilazodone, a novel SSRI antidepressant with 5-HT1A partial agonist properties: Diminished potentiation of chronic oral methylphenidate-induced dynorphin expression in the striatum in adolescent male rats
    Michael Hrabak, Rania Ahmed, Michelle G Soriano, Aidan Powell, Panayotis K. Thanos, Heinz Steiner · 2024 · Molecular Neurobiology
43. Methylphenidate reorganizes cortical hierarchy through dopaminergic modulation
    Dardo G. Tomasi, Peter Manza, Şükrü Barış Demiral, Weizheng Yan, Kylee B. Miller, Faith Veenker, Joshua Zhao, Christina Lildharrie, Michele-Vera Yonga, Sarah K. Abey et al. · 2025 · Nature Communications
44. Nuevas perspectivas de la estimulación magnética transcraneal en los trastornos psiquiátricos de la infancia y la adolescencia
    Belén Rubio · 2014 · Elsevier eBooks
45. Assessment of ADHD
    Lisa L. Weyandt, George J. DuPaul · 2012 · Springer eBooks
46. Psicoestimulantes y potenciadores cognitivos: corteza prefrontal, catecolaminas y trastorno por déficit de atención/hiperactividad
    Craig W. Berridge, David M. Devilbiss · 2012 · Psiquiatría Biológica
47. Efficacy and safety of compound porcine cerebroside and ganglioside injection (CPCGI) versus piracetam on cognition and functional outcomes for adults with traumatic brain injury: A study protocol for randomized controlled trial
    Tao Liu, Yunhu Yu, Liang Mi, Zhihao Zhao, Mingqi Liu, Jiao Wang, Xin Wang, Zhuang Sha, Meng Nie, Weiwei Jiang et al. · 2024 · Heliyon
48. Dopamine and Glutamate in Attention Deficit Hyperactivity Disorder
    James M. Swanson, Nora D. Volkow, Jeffrey H. Newcorn, B.J. Casey, Robert K. Moyzis, David K. Grandy, Michael I. Posner · 2005 · Humana Press eBooks
49. Central Nervous System
    S. Ted Treves, Harry T. Chugani, Blaise F. D. Bourgeois · 2007 · Springer eBooks
50. Methylphenidate induced tongue movements
    Anand Bhogaraju · 2019 · Archives of Mental Health
51. How Do We Navigate the Conceptual Tension Between Paradigms of ADHD?
    Tom Nicholson, Richard Philip Lee · 2026 · Neurodiversity
52. Effects of methylphenidate on impulsive choice and delay aversion in Lewis rats
    Kelsey Panfil, Robert Small, Kimberly Kirkpatrick · 2023 · Behavioural Pharmacology
53. Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
    Nowell Zammit, Richard Muscat · 2023 · Frontiers in Neuroscience
54. Pas si paradoxal … Neurobiologie du trouble déficit de l’attention–hyperactivité (TDAH) et mode d’action thérapeutique des psychostimulants
    Benjamin Rolland, Luc Zimmer, Hugo Prunier, Guillaume Sescousse · 2024 · Annales Médico-psychologiques revue psychiatrique
55. Cognitive Development Considerations for Long-term Safety Exposures in Children
    Mary E. Pipan, Paul P. Wang, Rebecca Thompson Penna · 2013 · Wiley eBooks
56. Role of dopamine in the pathophysiology of attention-deficit/hyperactivity disorder.
    Chandan J. Vaidya, Evan M. Gordon · 2012 · American Psychological Association eBooks
57. Stem Cell Therapy in Traumatic Brain Injury
    Sicong Tu, Jian Tu · 2017 · Stem cells in clinical applications
58. Hallusinosis due to methylphenidate overdose in an eight-year-old child: a case report
    Ender Atabay, Ayşe Rodopman Arman · 2017 · Marmara medical journal
59. The rate of dasotraline brain entry is slow following intravenous administration
    Robert Lew, Cristian C. Constantinescu, Daniel Holden, Richard E. Carson, Vincent M. Carroll, Gerald R. Galluppi, Kenneth S. Koblan, Seth C. Hopkins · 2020 · Psychopharmacology
60. Pharmacotherapy
    Lisa L. Weyandt, George J. DuPaul · 2012 · Springer eBooks
61. Attention deficit hyperactivity disorder in prison inmates
    Ylva Ginsberg · 2012 · Figshare
62. New insights on attention‐deficit/hyperactivity disorder pharmacogenomics
    Luís Augusto Rohde, Cristian Zeni, Guilherme V. Polanczyk, Mara Helena Hutz · 2004 · Drug Development Research
63. TDAH y su comorbilidad adictiva
    Mario Souza y Machorro, Víctor Manuel Guisa Cruz, Lino Díaz Barriga Salgado · 2005
64. Methylphenidate. An update on extended-release formulations
    Monica Zolezzi · 2007 · Neurosciences
65. An exploratory analysis of the performance of methylphenidate regimens based on a PKPD model of dopamine and norepinephrine transporter occupancy
    Sara Soufsaf, Philippe Robaey, Fahima Nekka · 2023 · Journal of Pharmacokinetics and Pharmacodynamics
66. Therapeutic Use of Dopamine Enhancers (Stimulants)
    Alessandro Zuddas, Sara Carucci · 2023 · Springer eBooks
67. Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance
    Hans Kirschner, Hanna M. Molla, Matthew R. Nassar, Harriet de Wit, Markus Ullsperger · 2025 · eLife
68. Development of benztropine-based DAT blockers for Parkinson's disease interventions: A biologic and synthetic overview
    Edson D. Hernández‐Velázquez, Rubén Chávez‐Rivera, Rafael Ortíz‐Alvarado, Cesar Rogelio Solorio‐Alvarado · 2025 · Bioorganic Chemistry
69. Pharmacokinetic and Pharmacodynamic Drug Interactions
    John Seth Markowitz, Kennerly S. Patrick · 2005 · Contemporary clinical neuroscience
70. Persistent Cognitive Deficits
    Hong Qu Yan, Nicole Danielle Osier, Jonathan R. Korpon, James W. Bales, Anthony E. Kline, Amy Kathleen Wagner, C. Edward Dixon · 2015
71. The Dopamine Transporter Gene (DAT1) in Obesity and Binge Eating Disorders
    Karen Wight, Caroline Reid‐Westoby, Caroline A. Davis · 2011 · Springer eBooks
72. ADHS und Sucht – Untersuchungen mit bildgebenden Verfahren
    Meline Stoy, Jana Wrase, Andreas Heinz, Andreas Ströhle · 2006 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
73. adolescents axis and catecholamines in obese children and Reduced exercise-associated response of the GH-IGF-I
    Pietro Renato Galassetti, Dan Michael Cooper, Alon Eliakim, Dan Nemet, Frank P Zaldivar, Robert G. McMurray, Floyd L. Culler, Jaime S. Rosa Duque, Rebecca L. Flores, Stacy R. Oliver et al. · 2013
74. Future Directions for Practice and Research
    Lisa L. Weyandt, George J. DuPaul · 2012 · Springer eBooks
75. Methylphenidate Abuse
    Maximilian Gahr, Paul Lukas Plener · 2016 · Elsevier eBooks
76. TITLE: Pharmacotherapy of Traumatic Brain Injury: State of the Science and the Road Forward Report of the Department of Defense Neurotrauma Pharmacology Workgroup RUNNING TITLE: Pharmacotherapy of Traumatic Brain Injury
    Ramon R. Diaz-Arrastia · 2013
77. Methylphenidate cross-sensitization with amphetamine is dose dependent but not age dependent
    Anthony Yuan, Natasha Kharas, Nicholas King, Pamela B. Yang, Nachum Dafny · 2022 · Behavioural Brain Research
78. Emerging tools for studying receptor endocytosis and signaling
    Pratiksha Pandita, Rhea Bhalla, Ashok Saini, Indra Mani · 2022 · Progress in molecular biology and translational science
79. Methylphenidate enhances or impairs the cognitive control of Pavlovian bias depending on working memory capacity
    Dirk E. M. Geurts, Hanneke E.M. den Ouden, Jennifer C. Swart, Monja I. Froböse, Sean James Fallon, Jennifer Louise Cook, Roshan Cools · 2026 · eLife
80. Advances in preschool psychopharmacology
    Joan L. Luby, Mark A. Riddle · 2009 · Mary Ann Liebert eBooks
81. ADHD in Adolescents (Middle and High School)
    Lisa L. Weyandt, George J. DuPaul · 2012 · Springer eBooks
82. Neurocognitive deficits in adult ADHD : preclinical and clinical studies
    Anneka Tomlinson · 2014 · Research Explorer (The University of Manchester)
83. What is the Role of Atomoxetine in the Management of ADHD?
    Russell A. Barkley · 2009 · The ADHD Report
84. Catecholamine Challenge Uncovers Distinct Mechanisms for Direct Versus Indirect, but Not Social Versus Non-Social, Learning
    Jennifer Louise Cook, Jennifer C. Swart, Monja I. Froböse, Andreea Oliviana Diaconescu, Dirk E. M. Geurts, Hanneke E.M. den Ouden, Roshan Cools · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
85. Role of alpha-synuclein in the regulation of dopamine neurotransmission in the striatum
    Heramb Chadchankar · 2013 · UEF eRepo (University of Eastern Finland)
86. Methylphenidate enhances or impairs the cognitive control of Pavlovian bias depending on working memory capacity
    Dirk E. M. Geurts, Hanneke E.M. den Ouden, Jennifer C. Swart, Monja I. Froböse, Sean James Fallon, Jennifer Louise Cook, Roshan Cools · 2024 · eLife
87. Genetic and Environmental Factors in Attention‐Deficit Hyperactivity Disorder
    Angela A. Baker, Michele Taylor, Jason R. Richardson · 2010
88. Hétérogénéité neuropsychologique et corrélats structurels du trouble déficit de l'attention / hyperactivité
    Thomas Villemonteix · 2015 · theses.fr (ABES)
89. Anatomical and Functional Neuroimaging Studies of Children and Adolescents With Attention Deficit Hyperactivity Disorder
    Jonathan C. Pfeifer, Melissa P. DelBello, Scott K. Holland · 2005 · Contemporary clinical neuroscience
90. JuvenileAdministrationofConcomitantMethylphenidate andFluoxetineAltersBehavioralReactivitytoReward-and Mood-RelatedStimuliandDisruptsVentralTegmentalArea GeneExpressioninAdulthood
    Brandon L. Warren, Sergio D. Iñiguez, Katherine N. Wright, EricM . Parise · 2011
91. Nuclear Neuroimaging in Child Psychiatry
    Amy Piepsz, Hamphrey Ham · 2004 · Springer eBooks
92. Die Behandlung der adulten Aufmerksamkeitsdefizit- Hyperaktivitäts-Störung (ADHS) mit Methylphenidat versus Atomoxetin: systematische Review
    Abteilung Allgemeine, Ärztlicher Direktor, Gerhard Buchkremer · 2007
93. Pediatric Psychopharmacological and Combined Interventions
    Margaret Semrud‐Clikeman, Phyllis Anne Teeter Ellison · 2009 · Springer eBooks
94. IMPACTO DO METILFENIDATO SOBRE A FREQUÊNCIA E A GRAVIDADE DAS CRISES EPILÉPTICAS EM CRIANÇAS COM O TRANSTORNO DE DÉFICIT DE ATENÇÃO E HIPERATIVIDADE (TDAH) ASSOCIADO A EPILEPSIAS DE DIFÍCIL CONTROLE.
    Kleber Santos · 2010 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
95. Long-Term Effects of Chronic Oral Ritalin Administration on Cognitive and Neural Development in Adolescent
    Margery C. Pardey, Natasha N. Kumar, Ann K. Goodchild, Kelly J. Clemens, Judi Homewood, Jennifer Louise Cornish · 2012
96. TDAH CON TRASTORNOS POR CONSUMO DE SUSTANCIAS
    Timothy E. Wilens · 2010 · Elsevier eBooks
97. Impact of Neurodevelopmental Genes on the Trajectory of ADHD Severity: A Pilot Study
    Agnieszka Mlodnicka · 2018 · CUNY Academic Works (City University of New York)
98. Pharmacology
    Francisco Ciruela, Rafael Franco, Javier Burgueño · 2007
99. Attention Deficit Hyperactivity Disorder
    K. E. Browman, Gerard B. Fox · 2007 · Elsevier eBooks
100. Neurobiological markers for remission and persistence of childhood attention-deficit/hyperactivity disorder
     Yuyang Luo · 2020